Karolinska Study Confirms Whole Genome Sequencing as Superior Diagnostic Tool for Rare Disease Identification

A 10-year study from Karolinska reveals how whole genome sequencing integrated into routine care provided diagnoses for 23% of rare disease patients.

By: AXL Media

Published: Mar 31, 2026, 8:58 AM EDT

Source: Information for this report was sourced from Karolinska Institutet.

Strategic Integration of Advanced Genomics into Routine Clinical Practice

The diagnostic landscape for rare diseases has undergone a fundamental shift following a ten-year initiative at Karolinska University Hospital. By integrating whole genome sequencing into standard medical evaluations, a multidisciplinary team has established a new model for identifying the underlying causes of complex conditions. A study published in Genome Medicine details how this collaborative approach between Karolinska Institutet and SciLifeLab has moved advanced genomic analysis out of the laboratory and directly into the patient care pathway. To date, 15,644 individuals have undergone complete genomic profiling, representing one of the largest clinical implementations of this technology to date.

The Diagnostic Superiority of Whole Genome Sequencing

Traditional genetic testing often focuses on specific genes or small segments of DNA, which can miss the complex variations responsible for rare conditions. In contrast, whole genome sequencing provides a comprehensive view of an individual's entire genetic makeup, allowing clinicians to detect changes that would otherwise remain unnoticed. The Karolinska study reports that 3,538 individuals—nearly a quarter of the total cohort—received a confirmed genetic diagnosis through this method. These diagnoses involved variations across more than 1,500 different genes, underscoring the immense diversity and biological complexity inherent in rare disease populations.

Impact on Pediatric Care and Target Treatment Strategies

The clinical significance of these findings is most pronounced among pediatric patients, who made up a large portion of the study's cohort. For many families, receiving a genetic diagnosis provides a vital explanation for a child's developmental or physical challenges, guiding future family planning and long-term follow-up care. More importantly, the diagnosis has led to immediate changes in medical management for several cases. According to Professor Anna Wedell, the team was able to offer targeted treatments for severe epilepsies and congenital metabolic disorders as a direct result of the sequencing, effectively preventing severe disease progression or early death.